Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.24.1.1.u2
Consolidated Balance Sheets - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Current Assets    
Cash and cash equivalents $ 75,764 $ 112,809
Marketable securities 113,599 107,912
Total Current Assets 189,363 220,721
Total Assets 189,363 220,721
Current Liabilities    
Accounts payable and accrued expenses 1,464,600 1,381,849
Total Current Liabilities 4,849,189 4,763,604
Total Liabilities 4,849,189 4,763,604
Stockholders’ Deficit    
Common stock, $0.0001 par value: authorized 500,000,000, 21,674,000 and 21,674,000 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively 2,167 2,167
Additional paid-in capital 810,048 810,048
Accumulated deficit (5,472,041) (5,355,098)
Total Stockholders’ Deficit (4,659,826) (4,542,883)
Total Liabilities and Stockholders’ Deficit 189,363 220,721
Related Party [Member]    
Current Liabilities    
Accounts payable - related party 911,659 911,659
Short -term advances - related party 1,673,558 1,673,558
Convertible note payable 25,000 25,000
Convertible note payable, net of debt discount of $5,670 and $8,504 as March 31, 2024 and December 31, 2023 173,192 173,192
Notes payable - related party - net of debt discount of $0 and $0 as of March 31, 2024 and December 31, 2023 106,850 106,850
Nonrelated Party [Member]    
Current Liabilities    
Convertible note payable, net of debt discount of $5,670 and $8,504 as March 31, 2024 and December 31, 2023 $ 494,330 $ 491,496